{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T08:01:27Z","timestamp":1774512087819,"version":"3.50.1"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008569","name":"Oklahoma Center for the Advancement of Science and Technology","doi-asserted-by":"publisher","award":["HR23-069"],"award-info":[{"award-number":["HR23-069"]}],"id":[{"id":"10.13039\/100008569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NR-52281"],"award-info":[{"award-number":["NR-52281"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.actbio.2023.12.039","type":"journal-article","created":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T12:24:56Z","timestamp":1703852696000},"page":"279-292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["N-dihydrogalactochitosan serves as an effective mucosal adjuvant for intranasal vaccine in combination with recombinant viral proteins against respiratory infection"],"prefix":"10.1016","volume":"175","author":[{"given":"Ashley R.","family":"Hoover","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil","family":"More","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaili","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Connor L.","family":"West","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3523-4937","authenticated-orcid":false,"given":"Trisha I.","family":"Valerio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Coline L.","family":"Furrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6277-5159","authenticated-orcid":false,"given":"Jacob P.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ningli","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Crystal","family":"Villalva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Alleruzzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel S.K.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomas","family":"Hode","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James F.","family":"Papin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7133-5794","authenticated-orcid":false,"given":"Wei R.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.actbio.2023.12.039_bib0001","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jcv.2011.07.017","article-title":"Disease burden of the most commonly detected respiratory viruses in hospitalized patients calculated using the disability adjusted life year (DALY) model","volume":"52","author":"Gaunt","year":"2011","journal-title":"J. Clin. Virol."},{"issue":"2","key":"10.1016\/j.actbio.2023.12.039_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2006.01.006","article-title":"Treatment of respiratory virus infections","volume":"70","author":"Abed","year":"2006","journal-title":"Antiviral Res."},{"issue":"4\u20135","key":"10.1016\/j.actbio.2023.12.039_bib0003","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3109\/08820131003680369","article-title":"Function of mucosa-associated lymphoid tissue in antibody formation","volume":"39","author":"Brandtzaeg","year":"2010","journal-title":"Immunol. Invest."},{"issue":"4","key":"10.1016\/j.actbio.2023.12.039_bib0004","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/nm1213","article-title":"Mucosal immunity and vaccines","volume":"11","author":"Holmgren","year":"2005","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.actbio.2023.12.039_bib0005","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/21645515.2016.1239668","article-title":"Current prospects and future challenges for nasal vaccine delivery","volume":"13","author":"Yusuf","year":"2017","journal-title":"Hum. Vaccin. Immunother."},{"issue":"8","key":"10.1016\/j.actbio.2023.12.039_bib0006","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nri3251","article-title":"Recent progress in mucosal vaccine development: potential and limitations","volume":"12","author":"Lycke","year":"2012","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.actbio.2023.12.039_bib0007","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/eji.200425730","article-title":"MyD88 is critical for the development of innate and adaptive immunity during acute lymphocytic choriomeningitis virus infection","volume":"35","author":"Zhou","year":"2005","journal-title":"Eur. J. Immunol."},{"issue":"37","key":"10.1016\/j.actbio.2023.12.039_bib0008","doi-asserted-by":"crossref","first-page":"E1025","DOI":"10.1503\/cmaj.190270","article-title":"Disseminated varicella zoster virus infection after vaccination with a live attenuated vaccine","volume":"191","author":"Dubey","year":"2019","journal-title":"Can. Med. Assoc. J."},{"issue":"9","key":"10.1016\/j.actbio.2023.12.039_bib0009","doi-asserted-by":"crossref","first-page":"e13563","DOI":"10.1111\/ctr.13563","article-title":"Vaccination of solid organ transplant candidates and recipients: guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"Danziger-Isakov","year":"2019","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.actbio.2023.12.039_bib0010","first-page":"45","article-title":"Inactivated viral vaccines","author":"Sanders","year":"2014","journal-title":"Vaccine Anal.: Strat., Principles, Control"},{"issue":"40","key":"10.1016\/j.actbio.2023.12.039_bib0011","doi-asserted-by":"crossref","first-page":"4827","DOI":"10.1016\/j.vaccine.2016.08.002","article-title":"Increased attenuation but decreased immunogenicity by deletion of multiple vaccinia virus immunomodulators","volume":"34","author":"Sumner","year":"2016","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.actbio.2023.12.039_bib0012","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/cmdc.201200487","article-title":"Modern subunit vaccines: development, components, and research opportunities","volume":"8","author":"Moyle","year":"2013","journal-title":"ChemMedChem"},{"issue":"6","key":"10.1016\/j.actbio.2023.12.039_bib0013","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/ni.2039","article-title":"Immunological mechanisms of vaccination","volume":"12","author":"Pulendran","year":"2011","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.actbio.2023.12.039_bib0014","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41573-021-00163-y","article-title":"Emerging concepts in the science of vaccine adjuvants","volume":"20","author":"Pulendran","year":"2021","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"1","key":"10.1016\/j.actbio.2023.12.039_bib0015","article-title":"Better adjuvants for better vaccines: progress in adjuvant delivery systems, modifications, and adjuvant-antigen codelivery","volume":"8","author":"Wang","year":"2020","journal-title":"Vaccines (Basel)"},{"issue":"9","key":"10.1016\/j.actbio.2023.12.039_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001397","article-title":"Inside the mucosal immune system","volume":"10","author":"McGhee","year":"2012","journal-title":"PLoS Biol."},{"key":"10.1016\/j.actbio.2023.12.039_bib0017","series-title":"Mucosal Immunology","first-page":"1183","article-title":"Chapter 61 - mucosal adjuvants: new developments and challenges","author":"Freytag","year":"2015"},{"issue":"5","key":"10.1016\/j.actbio.2023.12.039_bib0018","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1159\/000495897","article-title":"Type I interferons: distinct biological activities and current applications for viral infection","volume":"51","author":"Li","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"4","key":"10.1016\/j.actbio.2023.12.039_bib0019","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1080\/21645515.2015.1114195","article-title":"Induction of mucosal immunity through systemic immunization: phantom or reality?","volume":"12","author":"Su","year":"2016","journal-title":"Hum. Vaccin. Immunother."},{"issue":"3006","key":"10.1016\/j.actbio.2023.12.039_bib0020","article-title":"Combination of STING pathway agonist with saponin is an effective adjuvant in immunosenescent mice","volume":"10","author":"Vassilieva","year":"2019","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.actbio.2023.12.039_bib0021","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.celrep.2018.04.003","article-title":"STING-activating adjuvants elicit a th17 immune response and protect against mycobacterium tuberculosis infection","volume":"23","author":"Van Dis","year":"2018","journal-title":"Cell Rep."},{"issue":"7","key":"10.1016\/j.actbio.2023.12.039_bib0022","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1073\/pnas.1621363114","article-title":"cGAS is essential for the antitumor effect of immune checkpoint blockade","volume":"114","author":"Wang","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"5","key":"10.1016\/j.actbio.2023.12.039_bib0023","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.immuni.2011.05.001","article-title":"Myeloid C-type lectin receptors in pathogen recognition and host defense","volume":"34","author":"Osorio","year":"2011","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.actbio.2023.12.039_bib0024","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/j.vaccine.2006.11.034","article-title":"Chitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccination","volume":"25","author":"Zaharoff","year":"2007","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.actbio.2023.12.039_bib0025","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.immuni.2016.02.004","article-title":"The vaccine adjuvant chitosan promotes cellular immunity via DNA sensor cGAS-STING-dependent induction of type I interferons","volume":"44","author":"Carroll","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.actbio.2023.12.039_bib0026","doi-asserted-by":"crossref","unstructured":"A.R. Hoover, K. Liu, S.S. Kit Lam, C.F. Wong, A.D. Medcalf, X.-H. Sun, T. Hode, L. Alleruzzo, C. Furrer, T.I. Valerio, W.R. Chen, A novel biopolymer synergizes type I IFN and IL-1\u03b2 production through STING, Biorxiv (2022) 2022.07.22.501157.","DOI":"10.1101\/2022.07.22.501157"},{"key":"10.1016\/j.actbio.2023.12.039_bib0027","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/387023","article-title":"Chitin, chitosan, and glycated chitosan regulate immune responses: the novel adjuvants for cancer vaccine","volume":"2013","author":"Li","year":"2013","journal-title":"Clin. Develop. Immunol."},{"issue":"4","key":"10.1016\/j.actbio.2023.12.039_bib0028","doi-asserted-by":"crossref","first-page":"462","DOI":"10.3390\/polym10040462","article-title":"Biomedical applications of chitosan and its derivative nanoparticles","volume":"10","author":"Zhao","year":"2018","journal-title":"Polymers (Basel)"},{"issue":"5","key":"10.1016\/j.actbio.2023.12.039_bib0029","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3390\/md14050099","article-title":"\u201cThe good, the bad and the ugly\u201d of chitosans","volume":"14","author":"Bellich","year":"2016","journal-title":"Mar. Drugs"},{"issue":"5","key":"10.1016\/j.actbio.2023.12.039_bib0030","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1039\/c0pp00306a","article-title":"Preliminary safety and efficacy results of laser immunotherapy for the treatment of metastatic breast cancer patients","volume":"10","author":"Li","year":"2011","journal-title":"Photochem. Photobiol. Sci."},{"issue":"2","key":"10.1016\/j.actbio.2023.12.039_bib0031","doi-asserted-by":"crossref","first-page":"639","DOI":"10.7150\/thno.65773","article-title":"Antigen presentation and interferon signatures in B cells driven by localized ablative cancer immunotherapy correlate with extended survival","volume":"12","author":"Liu","year":"2022","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.actbio.2023.12.039_bib0032","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3390\/cells10030492","article-title":"Novel immune stimulant amplifies direct tumoricidal effect of cancer ablation therapies and their systemic antitumor immune efficacy","volume":"10","author":"Korbelik","year":"2021","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.actbio.2023.12.039_bib0033","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1128\/JVI.02012-06","article-title":"Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus","volume":"81","author":"McCray","year":"2007","journal-title":"J. Virol."},{"issue":"7\u20138","key":"10.1016\/j.actbio.2023.12.039_bib0034","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0264-410X(98)00252-7","article-title":"The adjuvants MF59 and LT-K63 enhance the mucosal and systemic immunogenicity of subunit influenza vaccine administered intranasally in mice","volume":"17","author":"Barchfeld","year":"1999","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.actbio.2023.12.039_bib0035","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1038\/s41467-021-21953-3","article-title":"The SARS-CoV-2 nucleocapsid protein is dynamic, disordered, and phase separates with RNA","volume":"12","author":"Cubuk","year":"2021","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.actbio.2023.12.039_bib0036","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1080\/20477724.2020.1838190","article-title":"Immunodominant regions prediction of nucleocapsid protein for SARS-CoV-2 early diagnosis: a bioinformatics and immunoinformatics study","volume":"114","author":"Dai","year":"2020","journal-title":"Pathog. Glob. Health"},{"issue":"4","key":"10.1016\/j.actbio.2023.12.039_bib0037","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41577-021-00583-2","article-title":"Mucosal vaccines \u2014 fortifying the frontiers","volume":"22","author":"Lavelle","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"12","key":"10.1016\/j.actbio.2023.12.039_bib0038","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/nm.3409","article-title":"Key roles of adjuvants in modern vaccines","volume":"19","author":"Reed","year":"2013","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.actbio.2023.12.039_bib0039","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.immuni.2006.08.007","article-title":"Type I interferons in host defense","volume":"25","author":"Stetson","year":"2006","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.actbio.2023.12.039_bib0040","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1002\/eji.200635993","article-title":"Early type\u2004I interferon-mediated signals on B cells specifically enhance antiviral humoral responses","volume":"36","author":"Fink","year":"2006","journal-title":"Eur. J. Immunol."},{"issue":"5","key":"10.1016\/j.actbio.2023.12.039_bib0041","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1084\/jem.20050821","article-title":"Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection","volume":"202","author":"Kolumam","year":"2005","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.actbio.2023.12.039_bib0042","doi-asserted-by":"crossref","first-page":"20085","DOI":"10.1038\/s41598-020-77077-z","article-title":"Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19","volume":"10","author":"Kuo","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.actbio.2023.12.039_bib0043","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/978-1-4939-6445-1_2","article-title":"Development of the CpG Adjuvant 1018: a Case Study","volume":"1494","author":"Campbell","year":"2017","journal-title":"Methods Mol. Biol."},{"issue":"2","key":"10.1016\/j.actbio.2023.12.039_bib0044","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1080\/08923970802629593","article-title":"Glycated chitosan as a new non-toxic immunological stimulant","volume":"31","author":"Song","year":"2009","journal-title":"Immunopharmacol. Immunotoxicol."},{"issue":"60","key":"10.1016\/j.actbio.2023.12.039_bib0045","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abj9256","article-title":"COVID-19 vaccine side effects: the positives about feeling bad","volume":"6","author":"Sprent","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.actbio.2023.12.039_bib0046","article-title":"ScRNA-seq reveals tumor microenvironment remodeling induced by local intervention-based immunotherapy","author":"Hoover","year":"2020","journal-title":"Biorxiv"},{"issue":"Suppl 3","key":"10.1016\/j.actbio.2023.12.039_bib0047","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1186\/ar567","article-title":"The instructive role of dendritic cells on T-cell responses","volume":"4","author":"Sallusto","year":"2002","journal-title":"Arthritis Res."},{"issue":"7","key":"10.1016\/j.actbio.2023.12.039_bib0048","doi-asserted-by":"crossref","first-page":"e937","DOI":"10.1002\/ctm2.937","article-title":"Single-cell RNA sequencing reveals localized tumour ablation and intratumoural immunostimulant delivery potentiate T cell mediated tumour killing","volume":"12","author":"Hoover","year":"2022","journal-title":"Clin. Transl. Med."},{"issue":"21","key":"10.1016\/j.actbio.2023.12.039_bib0049","doi-asserted-by":"crossref","first-page":"5335","DOI":"10.1158\/1078-0432.CCR-18-1126","article-title":"Local phototherapy synergizes with immunoadjuvant for treatment of pancreatic cancer through induced immunogenic tumor vaccine","volume":"24","author":"Zhou","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.actbio.2023.12.039_bib0050","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/jbm.a.35991","article-title":"N-dihydrogalactochitosan as a potent immune activator for dendritic cells","volume":"105","author":"El-Hussein","year":"2017","journal-title":"J. Biomed. Mater. Res. A"},{"issue":"8","key":"10.1016\/j.actbio.2023.12.039_bib0051","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.4049\/jimmunol.174.8.4465","article-title":"Cutting edge: type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation","volume":"174","author":"Curtsinger","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.actbio.2023.12.039_bib0052","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1101\/sqb.2013.78.021246","article-title":"IL-1\u03b2 strikingly enhances antigen-driven CD4 and CD8 T-cell responses","volume":"78","author":"Ben-Sasson","year":"2013","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"issue":"2758","key":"10.1016\/j.actbio.2023.12.039_bib0053","article-title":"Immunoinformatic analysis of SARS-CoV-2 nucleocapsid protein and identification of COVID-19 vaccine targets","volume":"11","author":"Oliveira","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.actbio.2023.12.039_bib0054","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bbrc.2021.01.073","article-title":"The Nucleocapsid protein triggers the main humoral immune response in COVID-19 patients","volume":"543","author":"Smits","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.actbio.2023.12.039_bib0055","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02002-20","article-title":"Identification of SARS-CoV-2 nucleocapsid and spike T-cell epitopes for assessing T-cell immunity","volume":"95","author":"Lee","year":"2021","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.actbio.2023.12.039_bib0056","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2021.04.006","article-title":"CD8(+) T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses","volume":"54","author":"Lineburg","year":"2021","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.actbio.2023.12.039_bib0057","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1007\/s11547-020-01237-4","article-title":"Chest CT features of coronavirus disease 2019 (COVID-19) pneumonia: key points for radiologists","volume":"125","author":"Carotti","year":"2020","journal-title":"Radiol. Med."},{"issue":"5","key":"10.1016\/j.actbio.2023.12.039_bib0058","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1440-1843.2009.01569.x","article-title":"Clinical challenges in managing bronchiectasis","volume":"14","author":"Tsang","year":"2009","journal-title":"respirol."},{"issue":"11","key":"10.1016\/j.actbio.2023.12.039_bib0059","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1016\/j.radcr.2020.08.008","article-title":"Rapid onset of bronchiectasis in COVID-19 Pneumonia: two cases studied with CT","volume":"15","author":"Ambrosetti","year":"2020","journal-title":"Radiol. Case Rep."},{"key":"10.1016\/j.actbio.2023.12.039_bib0060","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01760","article-title":"AS03- and MF59-adjuvanted influenza vaccines in children","volume":"8","author":"Wilkins","year":"2017","journal-title":"Front. Immunol."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706123007535?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706123007535?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:16:53Z","timestamp":1761675413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706123007535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":60,"alternative-id":["S1742706123007535"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2023.12.039","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N-dihydrogalactochitosan serves as an effective mucosal adjuvant for intranasal vaccine in combination with recombinant viral proteins against respiratory infection","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2023.12.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd on behalf of Acta Materialia Inc.","name":"copyright","label":"Copyright"}]}}